Sale!

Femibion Pregnancy 2 Metafolin + DHA 28 Tablets + 28 Capsules

Original price was: £11.98.Current price is: £3.40.

SKU: rxngqyyx28212 Category:

Description

FEMIBION PREGNANCY 2 METAFOLIN + DHA 28 TABLETS + 28 CAPSULES

s
Femibion Pregnancy 2 Metafolin + DHA 28 Tablets + 28 Capsules is a dietary supplement specifically designed to meet the nutritional needs of pregnant women, throughout pregnancy and until the end of breastfeeding. Its formula also contains DHA, a fatty acid from the omega 3 family.

Directions for use
For adults only. 1 tablet and 1 capsule per day from the 4th month of pregnancy until the end of breast-feeding.

Precautions for use
Do not exceed the recommended dose. Keep out of reach of young children. In the event of thyroid problems, ask your doctor for advice. Ask a health professional for advice. Store in a dry place at room temperature, not exceeding 25°C.

Composition
tablet: bulking agent: microcrystalline cellulose, magnesium oxide; calcium l-ascorbate; iron bisglycinate, coating agent : hydroxypropylmethylcellulose, colour: calcium carbonate, maltodextrin, nicotinamide, bulking agent: cross-linked sodium carboxymethylcellulose, acidifier: citric acid, coating agent : polyvinyl alcohol, polyethylene glycol, hydroxypropyl cellulose, talc, zinc oxide, dl-a-tocopherol acetate, calcium d-pantothenate, anti-caking agents : fatty acid magnesium salts, fatty acid, dicalcium phosphate, sucrose, modified starch, pyridoxine hydrochloride, thiamine mononitrate, starch, riboflavin, calcium l-methylfolate (metalfolin®), folic acid, potassium iodide, sodium selenate, d-biotin, cholecalciferol, cyanocobalamin.

capsule: concentrated dha-rich fish oil, fish gelatin, firming agent: glycerol, safflower oil, thickener: fatty acid mono- and diglyceride. dl-a-tocopherol acetate, lutein, antioxidant: tocopherol-rich extract, emulsifier: lecithin.

Reviews

There are no reviews yet.

Be the first to review “Femibion Pregnancy 2 Metafolin + DHA 28 Tablets + 28 Capsules”

Your email address will not be published. Required fields are marked *